Home › Funds › Stonepine Capital Management, LLC › INDV

Stonepine Capital Management, LLC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Stonepine Capital Management, LLC reported holding 100,000 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 2.75% of its reported portfolio and ranking #12 among its reported holdings. Stonepine Capital Management, LLC has disclosed INDV holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)100.00K sh
Reported value held$3.58M
Portfolio Weight2.75%
First reportedQ3 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's INDV position evolved

Stonepine Capital Management, LLC first disclosed a stake in INDV in Q3 2024 at 270,000 shares (US$2.6M). The position peaked in Q2 2025 at 350,000 shares, worth US$5.2M. Across 8 filings, Stonepine Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$3.6M. Notable position changes include a 71% trim in Q3 2025 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 270.00K $2.63M New
Q4 2024 305.00K $3.79M Add
Q1 2025 304.00K $2.90M Hold
Q2 2025 350.00K $5.16M Add
Q3 2025 100.00K $2.41M Reduce
Q4 2025 100.00K $3.59M Hold
Q2 2026 100.00K $4.10M New
Q3 2026 100.00K $3.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Stonepine Capital Management, LLC held INDV?

Stonepine Capital Management, LLC has disclosed INDV holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

What is Stonepine Capital Management, LLC's current position in INDV?

As of Q3 2026, Stonepine Capital Management, LLC holds 100.00K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $3.58M, representing 2.75% of its reported portfolio and ranking #12.

Has Stonepine Capital Management, LLC been buying or selling INDV?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC held unchanged its position in INDV. The position peaked in Q2 2025 at 350.00K shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.